Shares of Merck & Co. Inc. MRK slipped 1.46% to $93.35 Wednesday, on what proved to be an all-around mixed trading session ...

Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S.

In a report released yesterday, Luisa Hector from Berenberg Bank maintained a Buy rating on Merck & Company (MRK – Research Report), with a ...

The Board of Pharmac wishes to announce that its Chief Executive for the last 7 years, Sarah Fitt, has resigned effective from 30 May 2025. The Board and Pharmac are appreciative of all of Sarah's ...

The Board and Pharmac are appreciative of all of Sarah’s work over her times as Chief Executive and her previous 5 years in Senior Executive roles in the organisation.The Board of Pharmac wishes to ...

The chief executive of New Zealand medicines agency Pharmac for the past seven years, Sarah Fitt, has resigned. The agency’s board announced today, February 28, that Fitt will leave the role on May 30 ...

Feb 25 (Reuters) - Drugmaker Merck (MRK.N), opens new tab said on Tuesday it expects its top selling cancer therapy Keytruda to be selected in 2026 for government price setting, which would become ...

Merck shares have been under pressure amid disappointing sales trends for its Gardasil HPV vaccine. The company's broader drug portfolio continues to perform well and is driving a strong earnings ...

It's been a rough start to 2025 for Merck (NYSE: MRK) shareholders following a less-than-stellar fourth-quarter earnings report. Even as the pharmaceutical giant exceeded Wall Street estimates ...

How do you separate the solutions from the scams? If you can't access your feeds, please contact customer support. Thanks! Check your phone for a link to finish setting up your feed. Please enter ...

Lawsuits surrounding Merck's HPV vaccine Gardasil have been piling up for years now, but they've garnered increased public attention lately after HHS Secretary Robert F. Kennedy Jr.'s links to the ...